Skip to main content
Skip to "About this site"

12-Month Lobbying Summary - Organization

Apotex Inc. / Raymond Shelley, President, Apotex Canada

Registration Summary

Currently active - Last Updated: 2024-11-29

Who is lobbying?

Apotex Inc. (Address & business activities)

Raymond Shelley, President, Apotex Canada

Government Funding

Did Apotex Inc. request or receive government funding within the last 12 months? No

Coalition Members Information

Apotex Inc. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Apotex Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

APOTEX HOLD CO. INC. (Address information)
APOTEX INC. (Address information)
ARTEMIS INTERMEDIATE HOLDINGS, INC. (Address information)
ARTEMIS PARENT, INC. (Address information)

Affiliates as entered in previous versions
Registration version: 2
- APOTEX INC. (Address information)
- APOTEX PHARMACEUTICAL HOLDINGS INC. (Address information)
- ARTEMIS INTERMEDIATE HOLDINGS, INC. (Address information)
- ARTEMIS PARENT, INC. (Address information)

Other Affiliates

The activities of Apotex Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Apotex Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Government Procurement, Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Member(s) of the BC Legislative Assembly

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Chris Fournier
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Christine Renaud
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Raymond Shelley
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Matthew Southcott
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Francesco Tallarico
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Lobbyists in previous versions

In-house Lobbyists
Lobbyist	BC Former Public Office Holder Positions	Contributions
Fracesco Tallarico	Former Public Office Holder in BC: No	Contributions: No

Registration number: 10049-4636
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Lobbyists	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2024-11-21	No	Chris Fournier , Matthew Southcott	Sue Bouma, Executive Director, Clinical Services & Evaluation \| Pharmaceutical, Laboratory & Blood Services Division, Health John Capelli, Executive Director \| Pharmaceutical Policy, Legislation & Engagement, Health Mariana Diacu, Excutive Director \| Laboratory & Blood Services, Health Tijana Fazlagic, Executive Director \| PharmaCare Benefits Branch, Health Luba Kamenko, Director, Decision Support, Finance & Corporate Services \| Pharmaceutical, Blood&Services Division, Health Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory and Blood Services Division, Health Sarah Pugh, Executive Director \| Integrated Health Services Planning and Systems, Health Derek Tryan, Director, Divisional Executive Operations \| Pharmaceutical, Laboratory & Blood Services, Health	View
2024-08-26	No	Chris Fournier , Francesco Tallarico	Tijana Fazlagic, Executive Director \| PharmaCare Benefits Branch, Health Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory and Blood Services Division, Health	View

View all Lobbying Activity Reports

Date Modified:: 2024-12-13